Skip to content

Cell Source, Inc.: 10-K filed 2018-07-25

What Cell Source, Inc. reported in its annual report filed 2018-07-25 (fiscal FY 2017): 24 published measures, 72 facts as tagged in accession 0001165527-18-000154.

This filing

Form
10-K (annual report)
Filed
2018-07-25
Fiscal period
fiscal FY 2017
Accession
0001165527-18-000154 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-31531,677USD
At 2016-12-31211,103USD
At 2015-12-31214,829USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-12-315,089,051USD
At 2016-12-316,454,052USD
At 2015-12-315,973,078USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-31-4,557,374USD
At 2016-12-31-6,242,949USD
At 2015-12-31-5,758,249USD
At 2014-12-31-3,783,728USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-31371,048USD
At 2016-12-313,735USD
At 2015-12-316,944USD
At 2014-12-3119,480USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-3,082,510USD365
2016-01-01 to 2016-12-31-967,782USD366
2015-01-01 to 2015-12-31-2,504,105USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-2,287,814USD365
2016-01-01 to 2016-12-31-1,494,060USD366
2015-01-01 to 2015-12-31-2,000,610USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-12-312,655,127USD365
2016-01-01 to 2016-12-311,490,851USD366
2015-01-01 to 2015-12-311,988,074USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-31-14,552,887USD
At 2016-12-31-11,470,377USD
At 2015-12-31-10,502,595USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-12-31407USD
At 2015-12-311,267USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-12-3144,719USD365
2016-01-01 to 2016-12-31114,759USD366
2015-01-01 to 2015-12-31135,884USD365
2014-01-01 to 2014-12-31901,300USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-31531,677USD
At 2016-12-31210,696USD
At 2015-12-31213,562USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-01-01 to 2017-12-31174,970USD365
2016-01-01 to 2016-12-31243,425USD366
2015-01-01 to 2015-12-3132,612USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-315,089,051USD
At 2016-12-316,454,052USD
At 2015-12-315,924,936USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-01-01 to 2017-12-312,292,803USD365
2016-01-01 to 2016-12-312,318,606USD366
2015-01-01 to 2015-12-312,320,475USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-01-01 to 2017-12-31815,947USD365
2016-01-01 to 2016-12-31951,783USD366
2015-01-01 to 2015-12-311,097,580USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-01-01 to 2017-12-31637,318USD365
2016-01-01 to 2016-12-31554,185USD366
2015-01-01 to 2015-12-31392,925USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3125,349,236shares
At 2016-12-3124,679,256shares
At 2015-12-3123,929,256shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2017-12-3150,000USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-12-312,582USD
At 2016-12-312,175USD
At 2015-12-311,315USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-12-31821,244USD
At 2016-12-31875,211USD
At 2015-12-31441,485USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2017-12-310USD
At 2016-12-310USD
At 2015-12-310USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-12-31407USD365
2016-01-01 to 2016-12-31860USD366
2015-01-01 to 2015-12-31860USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-789,707USD365
2016-01-01 to 2016-12-311,350,824USD366
2015-01-01 to 2015-12-31-183,630USD365

Inspect the source

Entity
Cell Source, Inc. / CIK 0001569340
Captured
2026-09-20T09:20:59.488Z
SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))